1. Home
  2. Analysis
  3. Atropine-sulfate
  4. Soma

Atropine sulfate and Soma drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 21 people who take Atropine sulfate and Soma. Common interactions include anxiety among females, and anhedonia among males.

The phase IV clinical study analyzes what interactions people who take Atropine sulfate and Soma have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

21 people who take Atropine sulfate and Soma together, and have interactions are studied.

What is Atropine sulfate?

Atropine sulfate has active ingredients of atropine sulfate. Currently, eHealthMe is studying from 3,227 Atropine sulfate users.

What is Soma?

Soma has active ingredients of carisoprodol. It is used in muscle spasms. Currently, eHealthMe is studying from 16,986 Soma users.

Number of Atropine sulfate and Soma reports submitted per year:

Atropine sulfate and Soma drug interactions.

Common Atropine Sulfate and Soma drug interactions by gender *:

female:

  1. Anxiety
  2. Atelectasis
  3. Bronchopleural fistula
  4. Cardiomegaly
  5. Cerebrovascular disorder
  6. Cervical spinal stenosis
  7. Chest pain
  8. Chondromalacia
  9. Cyst
  10. Emphysema

male:

  1. Anhedonia
  2. Anxiety
  3. Blood urea nitrogen/creatinine ratio increased
  4. Bronchopleural fistula
  5. Bunion
  6. Cancer pain
  7. Cardiomegaly
  8. Cerebrovascular disorder
  9. Cervical spinal stenosis
  10. Chest pain

Common Atropine Sulfate and Soma drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Osteonecrosis
  3. Anhedonia
  4. Anxiety
  5. Blood creatinine increased
  6. Bone density decreased
  7. Emotional distress
  8. Hip arthroplasty
  9. Renal impairment
  10. Tooth loss

50-59:

  1. Cerebrovascular disorder
  2. Cervical spinal stenosis
  3. Chest pain
  4. Chondromalacia
  5. Cyst
  6. Depression
  7. Emphysema
  8. Empyema
  9. Eye discharge
  10. Faecal incontinence

60+:

  1. Depression
  2. Diarrhoea
  3. Insomnia
  4. Rotator cuff syndrome

Common conditions people have *:

  1. Bone Density Abnormal: 14 people, 66.67%
  2. Osteoporosis (bones weak and more likely to break): 5 people, 23.81%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 9.52%
  4. Hiv Infection: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Atropine sulfate and Soma?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Atropine sulfate drug interactions:

Browse interactions between Atropine sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Soma drug interactions:

Browse interactions between Soma and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atropine sulfate and carisoprodol (the active ingredients of Atropine sulfate and Soma, respectively), and Atropine sulfate and Soma (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Atropine sulfate and Soma.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.